Sales/Marketing

• 

  Valeant to resell female libido pill business 

  November 6, 2017 • Business Focus, Capital markets/Funding, Feature Slider, Feature-Home, Featured-Slides-Home, Sales/Marketing • 574

  Two years after buying a company that manufacturers female libido pills for $1 billion, Valeant Pharmaceuticals International...

• 

  Spotlight: A unique neurotech commercializaiton model proves successful

  June 30, 2017 • Feature, Opinions, Sales/Marketing • 763

  The Ontario Brain Institute (OBI) boasts a healthy portfolio of 56 companies that we support as part of our strategic mandate to...

• 

  Tragically Hip partners with Ontario cannabis producer

  May 30, 2017 • Business Focus, Deals/M&A/Collaboration, Feature Slider, Feature-Home, Featured-Slides-Home, Sales/Marketing • 931

  If you were ever in search any more indications that the local cannabis market is smoking, this just might be it. The iconic...

• 

  CDRD to help Novelogics get cancer immunotherapy to market

  May 19, 2017 • Business Focus, Deals/M&A/Collaboration, Sales/Marketing • 494

  Vancouver’s Novelogics Biotechnology Inc., has signed a research agreement with Canada’s national drug development and...

• 

  050| Bloom Burton & Co. Healthcare Investor Conference: Common biotech startup funding mistakes to avoid

  May 8, 2017 • Business Focus, Capital markets/Funding, Feature Slider, Featured-Slides-Home, Health, Podcast, Sales/Marketing • 835

  Biotechnology Focus was at the sixth annual Bloom Burton & Co. Healthcare Investor Conference in downtown Toronto. More than...

• 

  Merus Labs gets ok to sell Sintrom in Spain

  May 5, 2017 • Business Focus, Clinical Trials, Feature Slider, Feature-Home, Featured-Slides-Home, Health Care, Sales/Marketing • 439

  Earlier this week, Toronto’s Merus Labs International said it has received regulatory approval to sell its blood...

• 

  Valeant closer to paying down $5-B debt

  May 1, 2017 • Business Focus, Capital markets/Funding, Feature Slider, Feature-Home, Featured-Slides-Home, Policy/Regulatory/IP, Sales/Marketing • 338

  Valeant Pharmaceuticals today announced that a couple of financial developments is making helping the Laval, Que.-based pharma...

• 

  Tecentriq shows efficacy for metastatic bladder cancer

  April 19, 2017 • Bio-Medical, Business Focus, Clinical Trials, Drug Development, Feature Slider, Health, Health Care, Oncology, Sales/Marketing • 576

  Health Canada has approved with conditions the immunotherapy drug, Tecentriq, for the treatment of patients with locally advanced...

• 

  Knight Therapeutics commercializes MOVANTIK® in Canada

  March 13, 2017 • Business Focus, Sales/Marketing, Uncategorized • 620

  MONTREAL, QC -Canadian specialty pharmaceutical company Knight Therapeutics Inc. has commercially relaunched MOVANTIK, a...

• 

  Antibe Therapeutics enters into regional licensing deal

  March 6, 2017 • Business Focus, Feature, Sales/Marketing • 558

  TORONTO, ON- Antibe Therapeutics Inc. reports it has signed an exclusive licensing and distribution agreement with a...